The Effect of Turmeric Extract on the Treatment of Patients with Covid-19

Phase 3

• Conditions: People with COVID 19 whose disease has been confirmed by Real Time PCR..; Virus identified; U07.1

• Registration Number: IRCT20201111049348N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Includes people with laboratory confirmation of Quid 19 virus regardless of clinical signs and close association
Age over 15 years

Exclusion Criteria

History of drug allergies
History of allergies
Patients with immunodeficiency
Patients with hypertension
Group of patients with underlying disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interleukin 6( IL-6). Timepoint: Measurements of variable are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.;Interleukin One Beta( IL-1ß). Timepoint: Measurements of variable are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.;Alpha tumor necrosis factor(TNF-a). Timepoint: Measurements of variable are performed on the first day before the intervention and on the 10th day after the intervention. Method of measurement: Using the kit.